دورية أكاديمية
Author Correction: Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group
| العنوان: | Author Correction: Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group |
|---|---|
| المؤلفون: | Freyer, GillesAff1, Aff2, Aff3, IDs41467024489159_cor1, Floquet, AnneAff2, Aff4, Tredan, OlivierAff2, Aff5, Carrot, AuroreAff2, Aff6, Langlois-Jacques, CaroleAff2, Aff7, Lopez, JonathanAff2, Aff8, Selle, FrédéricAff2, Aff9, Abdeddaim, CyrilAff2, Aff10, Leary, AlexandraAff2, Aff11, Dubot-Poitelon, CoralineAff2, Aff12, Fabbro, MichelAff2, Aff13, Gladieff, LaurenceAff2, Aff14, Lamuraglia, MicheleAff2, Aff15 |
| المصدر: | Nature Communications. 15(1) |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 20411723 |
|---|---|
| DOI: | 10.1038/s41467-024-48915-9 |